mannyotero
@mannyotero
Dad, husband, son, brother, biotech/biopharma entrepreneur and C-suite leader with a passion for building high-performing teams on incredible journeys
ID: 16797402
http://www.linkedin.com/in/otero 16-10-2008 00:05:58
202 Tweet
124 Takipçi
408 Takip Edilen
Gene therapy expert Dr. Nicole Paulk discusses the science of AAV, where it is headed, programs in the pipeline, and how viral vector shortages are causing delays and backlog for clinical trials. What a wealth of info, must watch! #ATW23
I want to thank Howard Schultz. I am not a billionaire. I am inspired to live in a country where success and achievement is possible. To demonize those who have succeeded, when their journey has begun with nothing, is one of the worst behaviors we can exemplify for our children.
X (aka Twitter) continues to be a fast/efficient way to get updates and relevant biotech/biopharma news, including all things venture capital/funding. To those in this space, is X premium individual subscription worth it? Biotech Hangout Andy Biotech Daphne Zohar Bruce Booth Others?
Chad Steingraber Zzinovvv If one could get these groups to settle with XRP instead of using it as a means of transfer, imagine the tailwind for FXRP if they can position themselves in front of it over at Flare ☀️ Hugo Philion